Ferring Pharms. Inc. v. PAR Pharm., Inc.

Full title: FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA…

Court: United States Court of Appeals for the Federal Circuit

Date published: Jun 8, 2018

2017-2399 (Fed. Cir. Jun. 8, 2018)

Opinion

2017-2399

06-08-2018

FERRING PHARMACEUTICALS INC., FERRING INTERNATIONAL CENTER SA, Plaintiffs-Appellees v. PAR PHARMACEUTICAL, INC., Defendant-Appellant

MARY W. BOURKE, Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for plaintiffs-appellees. Also represented by DANIEL M. ATTAWAY, DANA KATHRYN SEVERANCE; JOHN W. COX, Atlanta, GA. RICHARD J. BERMAN, Arent Fox, LLP, Washington, DC, argued for defendant-appellant. Also represented by TANIEL ERMANO ANDERSON, JANINE A. CARLAN.

PER CURIAM

NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the District of Delaware in No. 1:15-cv-00173-RGA, Judge Richard G. Andrews.

JUDGMENT

MARY W. BOURKE, Womble Bond Dickinson (US) LLP, Wilmington, DE, argued for plaintiffs-appellees. Also represented by DANIEL M. ATTAWAY, DANA KATHRYN SEVERANCE; JOHN W. COX, Atlanta, GA. RICHARD J. BERMAN, Arent Fox, LLP, Washington, DC, argued for defendant-appellant. Also represented by TANIEL ERMANO ANDERSON, JANINE A. CARLAN. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (REYNA, SCHALL, and STOLL, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT June 8, 2018

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court